News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
690,579 Results
Type
Article (39794)
Company Profile (289)
Press Release (650496)
Section
Business (204242)
Career Advice (2011)
Deals (35411)
Drug Delivery (89)
Drug Development (80995)
Employer Resources (168)
FDA (16132)
Job Trends (14871)
News (345185)
Policy (32484)
Tag
Academia (2558)
Alliances (49326)
Alzheimer's disease (1290)
Approvals (16091)
Artificial intelligence (151)
Bankruptcy (354)
Best Places to Work (11639)
Biotechnology (205)
Breast cancer (195)
Cancer (1444)
Cardiovascular disease (116)
Career advice (1673)
Cell therapy (298)
Clinical research (64921)
Collaboration (521)
Compensation (294)
COVID-19 (2546)
C-suite (122)
Data (1429)
Diabetes (181)
Diagnostics (6182)
Earnings (84989)
Employer resources (146)
Events (110505)
Executive appointments (443)
FDA (16867)
Funding (482)
Gene therapy (208)
GLP-1 (613)
Government (4341)
Healthcare (18765)
Infectious disease (2640)
Inflammatory bowel disease (112)
Interviews (312)
IPO (16383)
Job creations (3641)
Job search strategy (1426)
Layoffs (424)
Legal (7873)
Lung cancer (213)
Manufacturing (213)
Medical device (13238)
Medtech (13243)
Mergers & acquisitions (19251)
Metabolic disorders (475)
Neuroscience (1635)
NextGen: Class of 2025 (6527)
Non-profit (4479)
Northern California (1796)
Obesity (271)
Opinion (186)
Parkinson's disease (105)
Patents (127)
People (56682)
Phase I (20197)
Phase II (28591)
Phase III (21300)
Pipeline (546)
Postmarket research (2565)
Preclinical (8581)
Radiopharmaceuticals (238)
Rare diseases (273)
Real estate (5909)
Regulatory (21755)
Research institute (2331)
Resumes & cover letters (350)
Southern California (1554)
Startups (3578)
United States (16053)
Vaccines (569)
Weight loss (188)
Date
Today (18)
Last 7 days (819)
Last 30 days (1838)
Last 365 days (34758)
2025 (910)
2024 (35336)
2023 (40162)
2022 (51251)
2021 (55793)
2020 (54157)
2019 (46604)
2018 (35088)
2017 (32171)
2016 (31585)
2015 (37659)
2014 (31432)
2013 (26461)
2012 (28657)
2011 (29324)
2010 (27376)
Location
Africa (714)
Arizona (200)
Asia (37449)
Australia (6127)
California (4067)
Canada (1516)
China (341)
Colorado (183)
Connecticut (189)
Europe (80360)
Florida (576)
Georgia (141)
Illinois (409)
Indiana (232)
Maryland (663)
Massachusetts (3160)
Michigan (180)
Minnesota (306)
New Jersey (1155)
New York (1156)
North Carolina (767)
Northern California (1796)
Ohio (150)
Pennsylvania (972)
South America (1096)
Southern California (1554)
Texas (587)
Utah (118)
Washington State (421)
690,579 Results for "mivi neuroscience inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
MIVI Neuroscience™ Presents Primary Endpoint Results from the EvaQ Trial — at the 2024 International Stroke Conference
MIVI Neuroscience, Inc. (Eden Prairie, MN) announces the primary endpoint results of its EvaQ Trial, a prospective, multi-center, global, single arm, FDA-regulated IDE trial study to evaluate the safety and effectiveness of the MIVI Q™ Revascularization System for treating acute ischemic stroke.
February 8, 2024
·
3 min read
Press Releases
Jupiter Neurosciences, Inc. Announces Closing of $11 million Initial Public Offering
December 4, 2024
·
3 min read
Press Releases
Jupiter Neurosciences, Inc. Announces Pricing of $11 million Initial Public Offering and Listing on Nasdaq
December 3, 2024
·
4 min read
BioMidwest
Clinical Trial Enrollment Complete for Study of MIVI Q™ Revascularization System that Treats Acute Ischemic Stroke
MIVI Neuroscience, Inc., innovator of next-generation neurointerventional medical devices, today announced that it has completed enrollment in the company’s clinical trial to assess the safety and effectiveness of the Q™ Revascularization System for the treatment of acute ischemic stroke (EVAQ Trial).
May 3, 2023
·
2 min read
Deals
Numinus Wellness Divests of Holdings in Alto Neuroscience Inc.
Numinus Wellness Inc. announces today that it has entered into an agreement to divest its holdings in Alto Neuroscience Inc. (“Alto”), a clinical-stage biopharmaceutical company.
February 1, 2024
·
3 min read
Press Releases
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Dr. Jonathan Javitt and Dr. David Feifel to Present Keynote Address, Beyond Ketamine Monotherapy: Combined Interventional Treatment of Suicidal Depression and PTSD, at the 8th Annual Neuroscience Innovation Forum in San Francisco
January 7, 2025
·
8 min read
Press Releases
Dr. Makoto Kuro-o, Pioneer of the Klotho Anti-Aging Gene, Joins Klotho Neurosciences, Inc. as Scientific Advisor
October 23, 2024
·
4 min read
Press Releases
Mytos Announces Manufacturing Collaboration with Aspen Neuroscience in Parkinson’s Disease
January 8, 2025
·
3 min read
Press Releases
Firefly Neuroscience Closes on Financing of up to $12.4 Million
December 31, 2024
·
5 min read
Press Releases
Reunion Neuroscience Announces Program Updates and Highlights Anticipated 2025 Milestones
January 6, 2025
·
5 min read
1 of 69,058
Next
